Double maintains 2 strategies that include DNTH - Dianthus Therapeutics, Inc.
Yahoo
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) Top-line MaGic results anticipated in September 2025 to be the first of three catalysts for the DNTH103 neuromuscular franchise by YE’26 Phase 3 CAPTIVATE trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) ongoing; interim responder analysis anticipated in 2H’26 Phase 2 MoMeNtum trial of DNTH103 in Multifocal Motor Neuropathy (MMN) ongoing; top-line results anticipated in 2H’26
Yahoo
MaGic trial exceeded enrollment target of 60 patients Top-line results anticipated this September will be the first of three DNTH103 catalysts by YE'26 Building a neuromuscular franchise with DNTH103 in gMG, CIDP and MMN with a potential best-in-class, potent classical pathway inhibitor intended as a self-administered autoinjector dosed once every two weeks NEW YORK and WALTHAM, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology com
Yahoo
NEW YORK and WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation at two upcoming investor events. Baird Biotech Discovery Series - Marino Garcia, Chief Executive Officer, will participate in a fireside chat webcast on Tuesday, May 6 at 1:30 p.m. EDT.Bank of
SeekingAlpha
Dianthus Therapeutics: Complement Therapy Developer With Long Road Ahead
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Yahoo
Dianthus Therapeutics ( NASDAQ:DNTH ) Full Year 2024 Results Key Financial Results Net loss: US$85.0m (loss widened by...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 54.33% | $4.85B | 0.35% |
IBB | 50.70% | $5.22B | 0.45% |
GNOM | 50.09% | $40.65M | 0.5% |
ARKG | 45.37% | $944.78M | 0.75% |
PBE | 44.81% | $214.12M | 0.58% |
BBH | 42.40% | $327.42M | 0.35% |
PINK | 41.52% | $131.52M | 0.5% |
FBT | 40.76% | $994.71M | 0.56% |
PTH | 40.42% | $96.56M | 0.6% |
XPH | 40.23% | $136.58M | 0.35% |
IWC | 39.35% | $766.88M | 0.6% |
IWO | 38.01% | $11.36B | 0.24% |
QQQJ | 37.64% | $610.08M | 0.15% |
KJUL | 37.17% | $113.35M | 0.79% |
XRT | 37.10% | $450.82M | 0.35% |
RSPA | 37.05% | $319.03M | 0.29% |
BALT | 36.83% | $1.44B | 0.69% |
ISCG | 36.66% | $645.00M | 0.06% |
RTH | 36.61% | $244.26M | 0.35% |
IWM | 36.45% | $63.95B | 0.19% |
Current Value
$19.001 Year Return
Current Value
$19.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VHC | -16.58% | $34.69M | +74.89% | 0.00% |
HEES | -13.97% | $3.52B | +99.54% | 1.15% |
SEG | -9.74% | $239.93M | -26.61% | 0.00% |
CME | -7.55% | $98.74B | +28.80% | 3.84% |
FMTO | -7.18% | $45.74M | -99.96% | 0.00% |
BNED | -5.75% | $371.19M | -38.80% | 0.00% |
PM | -5.71% | $263.27B | +68.03% | 3.17% |
PRT | -5.37% | $46.96M | +0.80% | 11.43% |
TRVG | -5.23% | $106.63M | +117.76% | 0.00% |
PULM | -5.17% | $23.82M | +239.64% | 0.00% |
USM | -5.00% | $5.19B | +38.83% | 0.00% |
STG | -4.73% | $27.05M | -37.35% | 0.00% |
LITB | -4.68% | $21.28M | -72.45% | 0.00% |
ARRY | -4.35% | $1.29B | -25.57% | 0.00% |
AIFU | -4.18% | $9.85M | -95.03% | 0.00% |
NEUE | -4.10% | $62.05M | +13.56% | 0.00% |
CBOE | -3.26% | $22.95B | +20.67% | 1.12% |
LNT | -3.20% | $15.85B | +18.74% | 3.19% |
AEP | -3.12% | $54.28B | +9.80% | 3.61% |
NEE | -3.09% | $153.47B | -2.43% | 2.84% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRMB | 0.11% | $12.11B | +56.30% | 1.15% |
AEE | -0.18% | $26.17B | +29.27% | 2.81% |
ZCMD | -0.23% | $32.45M | -11.38% | 0.00% |
BTCT | -0.31% | $25.35M | +93.08% | 0.00% |
ARLP | -0.33% | $3.42B | +17.02% | 10.52% |
COR | 0.36% | $55.43B | +28.90% | 0.56% |
KDP | 0.38% | $45.55B | -1.76% | 2.70% |
KO | -0.43% | $308.23B | +13.09% | 2.75% |
TEF | 0.44% | $27.20B | +8.80% | 6.44% |
ALHC | -0.46% | $2.95B | +113.16% | 0.00% |
STNG | -0.46% | $2.13B | -48.56% | 3.81% |
CTRE | 0.52% | $5.49B | +15.16% | 4.19% |
AWK | -0.54% | $27.37B | +4.54% | 2.22% |
MCK | 0.56% | $88.42B | +27.17% | 0.39% |
MSIF | -0.59% | $715.25M | +28.42% | 7.05% |
RILY | 0.66% | $102.47M | -88.22% | 14.71% |
CORT | -0.67% | $7.78B | +166.38% | 0.00% |
TPB | -0.69% | $1.29B | +113.31% | 0.40% |
NOC | 0.77% | $67.51B | -0.35% | 1.76% |
AVA | -0.85% | $3.09B | -0.21% | 6.26% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -26.76% | $109.64M | 0.85% |
TAIL | -26.54% | $140.49M | 0.59% |
BTAL | -22.71% | $361.41M | 1.43% |
ULST | -16.21% | $637.77M | 0.2% |
IVOL | -11.31% | $353.94M | 1.02% |
JMST | -8.27% | $3.65B | 0.18% |
XHLF | -7.97% | $1.46B | 0.03% |
SPTS | -7.69% | $5.76B | 0.03% |
GBIL | -7.16% | $6.17B | 0.12% |
UUP | -6.79% | $292.27M | 0.77% |
FTSD | -6.66% | $212.46M | 0.25% |
CTA | -6.59% | $1.05B | 0.76% |
USDU | -6.22% | $173.44M | 0.5% |
XONE | -5.86% | $603.24M | 0.03% |
IBTG | -5.42% | $1.88B | 0.07% |
BILS | -5.37% | $3.96B | 0.1356% |
CLIP | -5.03% | $1.50B | 0.07% |
IBTH | -4.82% | $1.53B | 0.07% |
SHYM | -4.61% | $322.93M | 0.35% |
UTWO | -4.55% | $387.71M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMNM | 47.71% | $696.10M | -44.44% | 0.00% |
IMVT | 46.84% | $2.36B | -55.78% | 0.00% |
CRNX | 45.53% | $2.92B | -39.88% | 0.00% |
COGT | 44.94% | $543.09M | -36.14% | 0.00% |
XNCR | 44.91% | $583.60M | -63.49% | 0.00% |
IDYA | 44.81% | $1.52B | -58.32% | 0.00% |
ACLX | 44.14% | $3.22B | +10.72% | 0.00% |
SYRE | 42.90% | $877.54M | -61.53% | 0.00% |
AUTL | 42.61% | $343.32M | -68.30% | 0.00% |
NTLA | 42.47% | $836.43M | -69.14% | 0.00% |
RNA | 42.31% | $3.49B | +0.87% | 0.00% |
CRSP | 42.01% | $3.14B | -34.78% | 0.00% |
EYPT | 41.69% | $393.60M | -54.31% | 0.00% |
RCKT | 41.36% | $724.54M | -71.26% | 0.00% |
BEAM | 41.31% | $1.73B | -27.49% | 0.00% |
OCUL | 40.69% | $1.14B | +14.35% | 0.00% |
DNLI | 40.51% | $2.06B | -30.04% | 0.00% |
DAWN | 39.82% | $624.39M | -61.57% | 0.00% |
ROIV | 39.60% | $7.68B | -5.70% | 0.00% |
RVMD | 39.59% | $7.35B | +1.15% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TBIL | 0.08% | $5.76B | 0.15% |
STXT | 0.13% | $134.15M | 0.49% |
IBTJ | -0.17% | $658.04M | 0.07% |
CMBS | 0.22% | $427.55M | 0.25% |
SPSK | -0.28% | $307.27M | 0.5% |
NEAR | 0.30% | $3.26B | 0.25% |
TPMN | -0.46% | $31.54M | 0.65% |
SPTI | 0.47% | $8.70B | 0.03% |
TDTT | 0.52% | $2.47B | 0.18% |
IEI | -0.54% | $16.09B | 0.15% |
VTIP | -0.54% | $14.78B | 0.03% |
SHY | 0.64% | $24.03B | 0.15% |
KRBN | -0.69% | $160.09M | 0.85% |
BIL | -0.93% | $45.95B | 0.1356% |
VGIT | 0.95% | $31.33B | 0.04% |
AGZ | 1.03% | $607.46M | 0.2% |
IBTK | 1.05% | $431.59M | 0.07% |
IBTI | -1.06% | $995.39M | 0.07% |
BSMW | -1.06% | $102.62M | 0.18% |
GOVT | 1.09% | $27.25B | 0.05% |